No where did I say the science isn’t real or promising. I’m simply stating that nearly every biotech that has a pending release of data at a conference gets hyped, overbought, and sold.
What happen here is not uncommon.
The pumpers make you think it’s going to go to $25 and then they sell the day before the news for a nice $3 per share profit.
Those who bought the hype are now upside down on their shares and can’t believe any other possibility.